日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: N6‑methyladenosine‑modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14‑dependent manner in renal cell carcinoma

更正：N6-甲基腺苷修饰的TRAF1通过METTL14依赖的方式调节肾细胞癌中的细胞凋亡和血管生成，从而促进舒尼替尼耐药性。

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-026-02596-8
Chen, Yuanlei; Lu, Zeyi; Qi, Chao; Yu, Chenhao; Li, Yang; Huan, Wang; Wang, Ruyue; Luo, Wenqin; Shen, Danyang; Ding, Lifeng; Ren, Liangliang; Xie, Haiyun; Xue, Dingwei; Wang, Mingchao; Ni, Kangxin; Xia, Liqun; Qian, Jun; Li, Gonghui
肿瘤
凋亡
表观遗传
肿瘤免疫
TRAF1
肾癌
细胞生物学
RAF1
MET
血管生成
发表日期：2026
文献求助 收藏

N-acetyltransferase 10 as a novel prognostic biomarker in papillary renal cell carcinoma: a machine learning and experimental validation study.

N-乙酰转移酶10作为乳头状肾细胞癌的新型预后生物标志物：机器学习和实验验证研究

期刊:Translational Cancer Research
影响因子:1.7
doi:10.21037/tcr-2024-2195
Li Liyang, Li Fan, Zhou Chenghao, Ni Kangxin, Hu Haiyi, Wang Mingchao, Wang Huan, Gao Lei
细胞生物学
肿瘤免疫
发表日期：2024
文献求助 收藏

Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature review

免疫疗法联合或不联合靶向治疗转移性上尿路尿路上皮癌：病例报告及文献综述

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e15813
Ni, Kangxin; Yu, Chenhao; Wang, Huailan; Zhu, Shibin; Yu, Shicheng; Li, Gonghui
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Single-port robot-assisted perineal radical prostatectomy with the da Vinci XI system: initial experience and learning curve using the cumulative sum method

使用达芬奇XI系统进行单孔机器人辅助会阴根治性前列腺切除术：基于累积和法的初步经验和学习曲线

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-023-02927-9
Yu, Chenhao; Xu, Li; Ye, Liyin; Zheng, Qiming; Hu, Haiyi; Ni, Kangxin; Zhou, Chenghao; Xue, Dingwei; Cheng, Sheng; Wang, Hui; Pak, Raymond Wei; Li, Gonghui
发表日期：2023
文献求助 收藏

N(6)-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma

N(6)-甲基腺苷修饰的TRAF1通过METTL14依赖的方式调节肾细胞癌中的细胞凋亡和血管生成，从而促进舒尼替尼耐药性。

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-022-01549-1
Chen, Yuanlei; Lu, Zeyi; Qi, Chao; Yu, Chenhao; Li, Yang; Huan, Wang; Wang, Ruyue; Luo, Wenqin; Shen, Danyang; Ding, Lifeng; Ren, Liangliang; Xie, Haiyun; Xue, Dingwei; Wang, Mingchao; Ni, Kangxin; Xia, Liqun; Qian, Jun; Li, Gonghui
肿瘤
凋亡
表观遗传
肿瘤免疫
TRAF1
肾癌
细胞生物学
RAF1
MET
血管生成
发表日期：2022
文献求助 收藏

Camrelizumab monotherapy leading to partial remission for relapsed upper tract urothelial carcinoma after radical nephroureterectomy: a case report

卡瑞利珠单抗单药治疗使根治性肾输尿管切除术后复发的上尿路尿路上皮癌部分缓解：病例报告

期刊:Translational Andrology and Urology
影响因子:1.7
doi:10.21037/tau-21-268
Ni, Kangxin; Wang, Zhenghui; Yu, Shicheng; Zheng, Jintong; Li, Gonghui
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏